XML 53 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cross currency swap derivative
Interest rate swap derivative
Total
Total
Cross currency swap derivative
Total
Interest rate swap derivative
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cross currency swap derivative
Accumulated Other Comprehensive Income (Loss)
Interest rate swap derivative
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2021             56,056              
Balance at the start of the period at Dec. 31, 2021 $ 1,998,461     $ 1,854,999     $ 56 $ 1,271,925 $ 0 $ 585,209 $ (2,191)     $ 143,462
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock-based compensation 11,646     11,646       11,646            
Exercise of options/stock-based awards by employees and directors (in shares) [1]             299              
Exercise of options/stock-based awards by employees and directors [1] 39     39       39            
Purchase of treasury stock (in shares)             (259)              
Purchase of treasury stock (17,964)     (17,964)         (17,964)          
Purchase of capped call transactions (24,538)     (24,538)       (24,538)            
Cash paid to noncontrolling interest (4,811)                         (4,811)
Cash dividend declared (27,143)     (27,143)           (27,143)        
Increase in noncontrolling interest in CD4 3,970                         3,970
Net income 77,157     65,841           65,841       11,316
Other comprehensive income (loss), net of related taxes:                            
Change in foreign currency translation adjustments (2,486)     (1,953)             (1,953)     (533)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge 8,370     8,370             8,370      
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax) (1,825) $ (1,825) $ 0 (1,825)             (1,825)      
Change in unrealized gains or losses on marketable securities available-for-sale 40     40             40      
Other 59     59             59      
Balance (in shares) at Dec. 31, 2022             56,096              
Balance at the end of the period at Dec. 31, 2022 2,020,975     1,867,571     $ 56 1,259,072 (17,964) 623,907 2,500     153,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock-based compensation 15,478     15,478       15,478            
Exercise of options/stock-based awards by employees and directors (in shares) [1]             123              
Exercise of options/stock-based awards by employees and directors [1] 314     314       314            
Change in noncontrolling interest rights (1,137)     901       901           (2,038)
Issuance of common stock (in shares)             4,140              
Issuance of common stock 341,671     341,671     $ 4 341,667            
Cash paid to noncontrolling interest (7,648)                         (7,648)
Cash dividend declared (28,412)     (28,412)           (28,412)        
Transaction with noncontrolling inetrest (29,055)     (2,663)       (2,663)           (26,392)
Net income 132,198     124,399           124,399       7,799
Other comprehensive income (loss), net of related taxes:                            
Change in foreign currency translation adjustments 1,257     822             822     435
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge (470)     (470)             (470)      
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax) (4,237) (4,237) 0 (4,237)             (4,237)      
Change in unrealized gains or losses on marketable securities available-for-sale 0                          
Other 53     53             53      
Balance (in shares) at Dec. 31, 2023             60,359              
Balance at the end of the period at Dec. 31, 2023 2,440,987     2,315,427     $ 60 1,614,769 (17,964) 719,894 (1,332)     125,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock-based compensation 20,197     20,197       20,197            
Exercise of options/stock-based awards by employees and directors (in shares) [1]             142              
Exercise of options/stock-based awards by employees and directors [1] 1     1     $ 1              
Cash paid to noncontrolling interest (4,707)                         (4,707)
Cash dividend declared (29,109)     (29,109)           (29,109)        
Buyout of class B membership in OPAL (1,418)     279       279           (1,697)
Net income 131,560     123,733           123,733       7,827
Other comprehensive income (loss), net of related taxes:                            
Change in foreign currency translation adjustments (8,232)     (7,052)             (7,052)     (1,180)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge 602     602             602      
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax)   $ 988 $ 13   $ 988 $ 13           $ 988 $ 13  
Change in unrealized gains or losses on marketable securities available-for-sale 0                          
Other 50     50             50      
Balance (in shares) at Dec. 31, 2024             60,501              
Balance at the end of the period at Dec. 31, 2024 $ 2,550,932     $ 2,425,129     $ 61 $ 1,635,245 $ (17,964) $ 814,518 $ (6,731)     $ 125,803
[1] Resulted in an amount lower than $1 thousand.